2nd Annual Medical Device Cybersecurity Risk Mitigation Conference: Speaker Interview Bill Hagestad Senior Principal Cyber Security Engineer, R&D Smiths Medical Bill will be one of the distinguished speakers at the 2nd Annual Medical Device Cybersecurity...
British pharmaceutical leader Indivior Plc announced this week its new drug application (NDA) to the U.S. Food and Drug Administration for its drug treating opioid use disorder (OUD). The drug, RBD-6000 acts as a monthly injectable opioid which in conjunction with...
The Democratic Republic of Congo’s health ministry has approved the use of a not-yet-licensed Merck vaccine to combat an outbreak of Ebola in the northeast which has killed four people. Clinical trials of the vaccine, rVSV-ZEBOV, last December showed a strong...
The Maryland state senate passed a bill this week which is aimed at lowering the amount of “superbugs” transmitted through the meat and dairy industry. The bill, entitled Keep Antibiotics Effective Act, will become effective in October of this year following Governor...
British PBM, Harvard Pilgrim, announced this week two outcome based contracts with pharmaceutical leader AstraZeneca. The first contract will monitor the outcomes of Brilinta, a treatment lowering the chance of another heart attack or death from a heart attack in...
